Financial statement analysis and common stock valuation
Financial Analyst
Stock Analysis on Net
If you are an investor who values fundamental analysis, you are in the right place. If you need comprehensive financial ratios, read on. You already know that the analysis of financial statements allows you to buy cheap and sell high, now it’s time to put it into practice. Stock Analysis on Net is here for you.
Today, try for free:
Bristol-Myers Squibb Co. (NYSE:BMY)
Analysis of Long-term (Investment) Activity Ratios
Quarterly Data
Measures how efficiently Bristol-Myers Squibb Co. generates revenues from its investments in fixed or total assets.
Enterprise Value to FCFF (EV/FCFF)
Free cash flow to the firm is the cash flow available to the Bristol-Myers Squibb Co. suppliers of capital after all operating expenses have been paid and necessary investments in working and fixed capital have been made.
Analysis of Solvency Ratios
Quarterly Data
Examines Bristol-Myers Squibb Co. capital structure in terms of the mix of its financing sources and the ability of the firm to satisfy its longer-term debt and investment obligations.
DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
Quarterly Data
An approach to decomposing Bristol-Myers Squibb Co. return on equity, return on assets, and net profit margin ratio as the product of other financial ratios.
Long-term Trends
Balance Sheet: Assets
The assets reports major classes and amounts of resources owned or controlled by Bristol-Myers Squibb Co..
Analysis of Short-term (Operating) Activity Ratios
Quarterly Data
Evaluates revenues and output generated by the Bristol-Myers Squibb Co. assets. Operating performance ratios describe the relationship between the Bristol-Myers Squibb Co. level of operations and the assets needed to sustain operating activities.
Enterprise Value to EBITDA (EV/EBITDA)
To calculate EBITDA analysts start with net earnings. To that earnings number, interest, taxes, depreciation, and amortization are added. EBITDA as a pre-interest number is a flow to all providers of capital.
Analysis of Profitability Ratios
Quarterly Data
Measures the income of Bristol-Myers Squibb Co. relative to its revenues and invested capital.
Analysis of Profitability Ratios
Measures the income of Bristol-Myers Squibb Co. relative to its revenues and invested capital.
Price to FCFE (P/FCFE)
Free cash flow to equity is the cash flow available to Bristol-Myers Squibb Co. equity holders after all operating expenses, interest, and principal payments have been paid and necessary investments in working and fixed capital have been made.
Analysis of Liquidity Ratios
Quarterly Data
Measures the adequacy of a Bristol-Myers Squibb Co. cash resources to meet its near-term cash obligations.
Common-Size Income Statement
Quarterly Data
Income statement components (revenues and expenses) shown as percentage of total sales.
What’s new
Wednesday, March 25, 2026
Adobe Inc. (NASDAQ:ADBE) quarterly report
for quarterly period ended February 27, 2026
Monday, March 23, 2026
Lowe’s Cos. Inc. (NYSE:LOW) annual report
for fiscal year ended January 30, 2026
Thursday, March 19, 2026
Micron Technology Inc. (NASDAQ:MU) quarterly report
for quarterly period ended February 26, 2026
Thursday, March 19, 2026
Accenture PLC (NYSE:ACN) quarterly report
for quarterly period ended February 28, 2026
Thursday, March 19, 2026
FedEx Corp. (NYSE:FDX) quarterly report
for quarterly period ended February 28, 2026
Wednesday, March 18, 2026
Home Depot Inc. (NYSE:HD) annual report
for fiscal year ended February 1, 2026